A patient experiencing a severe asthma exacerbation presents with respiratory alkalosis and hypoxemia, and is not responding adequately to Albuterol inhaler and nebulized bronchodilators. What is the most appropriate next step in managing this patient's condition?

B) Initiate systemic corticosteroids

A) Increase the frequency of Albuterol nebulization

B) Initiate systemic corticosteroids

C) Administer intravenous antibiotics

A patient with a history of asthma presents with increased wheezing, intercostal retractions, and reports worsening symptoms despite frequent use of an Albuterol inhaler. The clinical team notes an elevated eosinophil count and hyperinflation on chest X-ray. Which of the following interventions should the nurse anticipate to address the patient's current condition effectively?

B) Administer systemic corticosteroids to reduce inflammation.

A) Increase the frequency of Albuterol nebulizer treatments.

B) Administer systemic corticosteroids to reduce inflammation.

C) Initiate a course of broad-spectrum antibiotics to treat suspected pneumonia.

D) Prepare for intubation and mechanical ventilation due to respiratory failure.

A patient with an asthma exacerbation is receiving nebulized bronchodilators and supplemental oxygen but continues to show significant accessory muscle use and wheezing. Intravenous methylprednisolone has been initiated. Which nursing intervention is most appropriate to assist in improving the patient's ventilation at this time?

C) Instruct the patient on pursed-lip breathing techniques

A) Encourage the patient to take deep breaths rapidly

B) Position the patient in a supine position to rest

C) Instruct the patient on pursed-lip breathing techniques

D) Reduce the oxygen flow rate to prevent oxygen toxicity

A patient with an asthma exacerbation is being treated with nebulized bronchodilators, supplemental oxygen, and intravenous methylprednisolone. Despite treatment, the patient continues to use accessory muscles for breathing, and wheezing persists. What is the next most appropriate nursing action to assist in improving the patient's respiratory status?

C) Encourage pursed-lip breathing and assist the patient in maintaining an upright position.

A) Increase the oxygen flow rate to 6 liters per minute.

B) Administer a dose of an oral leukotriene receptor antagonist.

C) Encourage pursed-lip breathing and assist the patient in maintaining an upright position.

D) Discontinue the nebulized bronchodilators and switch to oral bronchodilators.

A patient experiencing an asthma exacerbation is showing signs of respiratory fatigue with a pH of 7.32 and PaCO2 of 52 mmHg. Which intervention should the nurse prioritize to address the patient's current condition?

B) Initiate non-invasive positive pressure ventilation (NIPPV)

A) Administer additional doses of bronchodilators

B) Initiate non-invasive positive pressure ventilation (NIPPV)

C) Increase supplemental oxygen flow rate

D) Prepare for immediate intubation

A patient with asthma exacerbation is showing signs of respiratory fatigue and potential impending respiratory failure, despite supplemental oxygen therapy. An ABG analysis reveals a pH of 7.32, PaCO2 of 52 mmHg, and HCO3- of 24 mEq/L. Which nursing intervention is most appropriate to address the patient's current respiratory status?

A) Increase the flow rate of supplemental oxygen to improve oxygenation.

B) Position the patient in a high Fowler's position to facilitate lung expansion.

D) Administer a bronchodilator via nebulization to manage airway obstruction.

A patient with respiratory distress is receiving non-invasive positive pressure ventilation (NIPPV) and bronchodilator therapy. The nurse notes the development of mild wheezing and an elevated heart rate. Which action should the nurse prioritize to address the patient's condition?

A) Increase the frequency of nebulized albuterol therapy

B) Administer a dose of intravenous corticosteroids

C) Initiate supplemental oxygen therapy at a higher flow rate

D) Encourage deep breathing exercises to improve ventilation

A patient receiving non-invasive positive pressure ventilation (NIPPV) for respiratory distress shows mild wheezing and an elevated heart rate. The clinical team decides to optimize her bronchodilator therapy. Which nursing intervention is most critical to ensure the effectiveness of the adjusted treatment regimen?

C) Educate the patient on proper inhaler technique to ensure medication efficacy.

A) Monitor the patient's respiratory and heart rate every hour.

B) Assess the patient's hydration status and encourage fluid intake.

C) Educate the patient on proper inhaler technique to ensure medication efficacy.

D) Schedule follow-up arterial blood gas analysis to evaluate acid-base balance.

A patient with a history of asthma exacerbation is experiencing chest discomfort, mild tachypnea, and asymmetrical chest movement with decreased breath sounds on the right side. Given these clinical findings, what is the nurse’s priority action while awaiting the chest X-ray results?

B) Prepare for potential needle decompression in case of pneumothorax.

A) Increase the oxygen flow rate to improve oxygenation.

B) Prepare for potential needle decompression in case of pneumothorax.

C) Administer an additional dose of bronchodilator to relieve wheezing.

D) Position the patient in a semi-Fowler's position to ease breathing.

A patient with a severe asthma exacerbation is experiencing chest discomfort, tachypnea, and asymmetrical chest movement with decreased breath sounds on the right side. What is the nurse's priority intervention while awaiting the chest X-ray results to confirm a pneumothorax?

B) Prepare for potential chest tube insertion by gathering needed supplies.

A) Increase the oxygen flow rate to improve saturation.

B) Prepare for potential chest tube insertion by gathering needed supplies.

C) Administer an additional dose of bronchodilator to relieve wheezing.

D) Position the patient in a semi-Fowler's position to aid breathing.

Deterioration of asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - Chronic inflammation of the airways leads to swelling and increased mucus production, causing obstruction and reduced airflow. This is primarily driven by immune system responses to allergens or irritants, involving cells such as eosinophils and T-lymphocytes.

• Secondary mechanism: Bronchoconstriction - Smooth muscle contraction around the airways is triggered by inflammatory mediators (e.g., histamine, leukotrienes) during an asthma attack, leading to narrowed airways and difficulty breathing.

• Key complication: Airway remodeling - Persistent inflammation and bronchoconstriction can cause structural changes in the airway, such as thickening of the airway walls and increased smooth muscle mass, resulting in decreased lung function over time and increased risk of asthma exacerbations.

Patient Profile

Demographics:

32, female, elementary school teacher

History:

• Key past medical history: Asthma diagnosed at age 12, seasonal allergies, occasional GERD

• Current medications: Albuterol inhaler as needed, Montelukast 10 mg daily, Fluticasone inhaler twice daily

• Allergies: Penicillin, dust mites

Current Presentation:

• Chief complaint: Increased difficulty in breathing and persistent cough

• Key symptoms: Wheezing, chest tightness, shortness of breath especially at night, fatigue, mild fever

• Vital signs: Temperature 100.4°F, Heart rate 110 bpm, Respiratory rate 24 breaths/min, Blood pressure 130/85 mmHg, Oxygen saturation 92% on room air

Section 1

As the clinical team proceeds with the initial assessment, further evaluation reveals that the patient's wheezing has intensified, and she is exhibiting accessory muscle use, particularly intercostal retractions, indicating increased respiratory effort. The auscultation of her lungs reveals diffuse wheezes throughout all lung fields, with diminished air entry noted more prominently in the bases. The patient reports that her symptoms have progressively worsened over the past 48 hours, despite frequent use of her Albuterol inhaler. Additionally, she mentions that her nighttime symptoms have significantly disrupted her sleep, contributing to her fatigue.

In light of these findings, a chest X-ray and complete blood count (CBC) are ordered to investigate potential complications such as pneumonia or an underlying infection that may be exacerbating her asthma. The chest X-ray shows hyperinflation but no focal infiltrates, ruling out pneumonia. However, the CBC reveals an elevated white blood cell count, primarily eosinophils, suggesting an exacerbated allergic or inflammatory response. Concurrently, an arterial blood gas (ABG) analysis is performed, showing respiratory alkalosis with a pH of 7.47, PaCO2 of 32 mmHg, and PaO2 of 68 mmHg, indicative of hyperventilation due to increased respiratory distress and hypoxemia.

The clinical reasoning process now focuses on the possible progression to a severe asthma exacerbation, with the risk of further complications such as respiratory failure if not promptly addressed. The team considers adjusting her treatment regimen, potentially escalating to systemic corticosteroids to manage the inflammation more effectively. The patient's response to initial interventions, including administration of nebulized bronchodilators and supplemental oxygen, will be critical in determining the next steps in her care. This evolving scenario underscores the need for close monitoring and reevaluation to prevent further deterioration and ensure a favorable outcome.

Section 2

In response to the initial interventions, the clinical team closely monitors the patient's vital signs and overall status. After administering nebulized bronchodilators and supplemental oxygen, her respiratory rate slightly decreases from 28 to 24 breaths per minute, and her oxygen saturation improves to 92% on 4 liters of oxygen via nasal cannula. However, despite these interventions, the patient continues to exhibit significant accessory muscle use, and her wheezing persists, indicating only partial relief of her symptoms. Her heart rate remains elevated at 110 beats per minute, reflecting ongoing physiological stress.

Given the limited response to bronchodilators and oxygen therapy, the team decides to initiate systemic corticosteroids, specifically intravenous methylprednisolone, to address the underlying inflammation contributing to her asthma exacerbation. The decision is based on the elevated eosinophil count, suggesting an allergic component that may benefit from anti-inflammatory treatment. Concurrently, the patient is encouraged to maintain an upright position to facilitate lung expansion and is instructed on pursed-lip breathing techniques to improve ventilation.

As the team continues to evaluate her progress, they remain vigilant for signs of potential complications, such as exhaustion from respiratory effort or a shift towards respiratory acidosis if her condition worsens. The patient is reassessed frequently, with plans for repeat arterial blood gas analysis and continuous pulse oximetry to guide further management. This proactive approach aims to stabilize her condition and prevent progression to more severe respiratory compromise, highlighting the importance of timely and targeted interventions in managing asthma exacerbations.

Section 3

As the clinical team continues to monitor the patient, they note a change in her status that requires immediate attention. Approximately two hours after the administration of intravenous methylprednisolone, the patient begins to exhibit increased fatigue and a slight decline in mental alertness. Her respiratory effort becomes more labored, with an increase in accessory muscle use and a new onset of nasal flaring. Despite supplemental oxygen therapy, her oxygen saturation drops to 88%, and her respiratory rate climbs back to 30 breaths per minute. These findings suggest the development of respiratory fatigue and potential impending respiratory failure.

In response to these concerning signs, the team quickly reassesses the patient. A repeat arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 52 mmHg, and HCO3- of 24 mEq/L, indicating a shift towards respiratory acidosis due to hypoventilation. The elevated PaCO2 confirms inadequate ventilation and points to the need for more aggressive respiratory support. Given these developments, the team decides to escalate her care by considering non-invasive positive pressure ventilation (NIPPV) to reduce the work of breathing, improve alveolar ventilation, and correct the acid-base imbalance. This intervention aims to stabilize her condition and prevent the need for intubation, while the team evaluates the efficacy of the current treatment regimen and explores additional therapeutic options.

The patient’s changing clinical picture emphasizes the importance of continuous monitoring and timely intervention in managing asthma exacerbations. The team's ability to recognize signs of deterioration and promptly adjust the treatment plan underscores the critical role of clinical reasoning in preventing further complications and optimizing patient outcomes. As they proceed with the updated management strategy, the focus remains on ensuring the patient's safety and facilitating recovery, while being prepared to address any new challenges that may arise.

Section 4

As the team implements non-invasive positive pressure ventilation (NIPPV), they closely monitor the patient's response to this intervention. Initially, there is a slight improvement in her respiratory effort, as she appears less fatigued and her breathing becomes more regular. Her oxygen saturation increases to 92%, offering a hopeful sign that the ventilation support is enhancing her alveolar ventilation. However, the team remains vigilant, aware that respiratory acidosis could still pose a risk if not fully addressed. A repeat arterial blood gas analysis is scheduled for the next hour to assess any changes in her acid-base status and the effectiveness of the NIPPV.

During this period, the nurse conducts a thorough assessment and notes that while the patient's respiratory status shows some signs of stabilization, there is a new development: the patient begins to exhibit mild wheezing on auscultation, suggesting persistent bronchoconstriction. Her heart rate is elevated at 110 beats per minute, indicating increased cardiac workload, likely due to the persistent respiratory distress. The nurse communicates these findings to the rest of the team, prompting a review of her bronchodilator regimen and consideration of additional pharmacologic interventions to address the bronchospasm more effectively.

Recognizing these changes, the clinical team decides to optimize the patient's current treatment plan. They adjust her bronchodilator therapy by increasing the frequency of nebulized albuterol and adding ipratropium to enhance bronchodilation. The team also ensures that the patient remains well-hydrated to facilitate mucociliary clearance. As these adjustments are made, the team prepares for the possibility of further complications, such as pneumothorax or infection, which could arise from ongoing respiratory distress. The focus remains on continuous evaluation and adaptation of the treatment strategy to support the patient's recovery and prevent escalation to more invasive measures.

Section 5

As the team continues to monitor the patient following the adjustments to her bronchodilator therapy, there is a noticeable change in her status. Approximately one hour after the intervention, a repeat arterial blood gas analysis reveals a partial improvement in her acid-base balance. The pH level has increased slightly to 7.32, indicating a partial resolution of respiratory acidosis, and the partial pressure of carbon dioxide (PaCO2) has decreased to 55 mmHg. These results suggest that the augmented bronchodilator regimen and NIPPV are beginning to take effect, improving her ventilation and gas exchange.

However, despite these positive developments, the patient’s clinical picture is complicated by the onset of a new challenge. She begins to complain of chest discomfort and exhibits mild tachypnea with a respiratory rate that has increased to 32 breaths per minute. Her oxygen saturation remains stable at 93%, but the persistent wheezing has become more pronounced upon auscultation. The nurse observes that the patient’s chest appears asymmetrical with decreased breath sounds on the right side, raising a concern for potential pneumothorax. The team orders an urgent chest X-ray to investigate this possibility further.

This new complication necessitates a prompt response from the clinical team. While awaiting the imaging results, the team prepares for potential interventions, which may include needle decompression or chest tube placement if a pneumothorax is confirmed. Concurrently, they continue to adjust the patient's NIPPV settings to optimize her respiratory effort and maintain adequate oxygenation. The team’s focus remains on balancing the immediate management of the suspected pneumothorax while ensuring the ongoing support for her asthma exacerbation, highlighting the importance of dynamic clinical reasoning in adapting to evolving patient needs.